secwatch.observer — SEC 8-K summary
======================================

Issuer:     Annovis Bio, Inc. (ANVS)
CIK:        0001477845
Form:       8-K
Filed at:   2024-12-11T23:59:59+00:00
Accession:  0001104659-24-127626
Event type: other
Sentiment:  neutral
Materiality: 0.40
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Annovis Bio presents investor deck on path to NDA for Alzheimer's and Parkinson's
--------------------------------------------------------------------------------

- Presentation on December 11, 2024 outlines development path to NDA for Alzheimer's and Parkinson's.
- Deck used during live webcast; full content not available in this filing excerpt.
- No specific clinical data, financial figures, or milestone dates disclosed in the provided text.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477845/000110465924127626/0001104659-24-127626-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477845/000110465924127626/tm2430782d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-127626

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer